Mar 05, 2019
Biotech Companies Intensify Research Into New Therapies to Combat Cancer
Feb 12, 2019
Pioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer Research
Feb 06, 2019
Perlmutter Cancer Center Earns Comprehensive Status from the National Cancer Institute
Feb 04, 2019
Neurotrope Announces Cooperative Research and Development Agreement for Bryostatin-1 with the National Cancer Institute
Jan 29, 2019
Lung-MAP Precision Medicine Trial Expands To Include More Patients
Jan 06, 2019
Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alliance in Cancer Drug Development
Dec 20, 2018
Distinguished Breast Cancer Expert, Dr. George W. Sledge, Jr., M.D., to join the Board of Tessa Therapeutics
Dec 19, 2018
The EndBrainCancer Initiative Partners with the National Cancer Institute (NCI) for Advocacy, Education and Placement into Clinical Trials for Brain Cancer Patients
Nov 29, 2018
Synbal Joins BioLabs San Diego with a Fast-Track SBIR Grant from the NCI
Nov 29, 2018
Tocagen and NRG Oncology to Collaborate on a Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma
Nov 27, 2018
Reliance on "YouTube Medicine" May Be Dangerous for Those Concerned About Prostate Cancer
Nov 26, 2018
Machavert Pharmaceuticals Unveils a New Bioactive Lipid Drug Candidate for Cancer Treatment
Nov 12, 2018
Privo Technologies Receives a $3M Award
Nov 08, 2018
Mediaplanet Releases New Cancer Care Campaign in Partnership with Biden Cancer Initiative and More
Nov 05, 2018
Frederick National Laboratory Names Chief Science Officer
Oct 30, 2018
Octo Awarded $75M Contract to Provide Full Range of Information Technology & Infrastructure Services to the National Cancer Institute
Oct 30, 2018
Dr. Andrew C. Von Eschenbach Joins Bausch Health Board Of Directors
Oct 30, 2018
Temple University's Katz School of Medicine, Hunter College Awarded $13.5M NCI/NIH Grant For Cancer Health Disparities
Oct 29, 2018
Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.
Oct 23, 2018
Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing